Truist Initiates Teva Pharmaceuticals (TEVA) Coverage with Buy, $25 Price Target

finance.yahoo.com/news/truist-initiates-teva-pharmaceuticals-teva-175009311.html

In This Article:
On Tuesday, May 27, an analyst from Truist Securities initiated coverage on Teva Pharmaceutical Industries Limited (NYSE:TEVA) with a Buy rating and a price target of $25.
Teva Pharma is an Israeli pharmaceutical company best known as one of the world’s largest…

This story appeared on finance.yahoo.com, 2025-05-29 17:50:09.
The Entire Business World on a Single Page. Free to Use →